{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-089612","form_type":"8-K","ticker":"INTS","cik":"0001567264","company_name":"INTENSITY THERAPEUTICS, INC.","filed_at":"2023-11-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.561145+00:00","generated_at":"2026-06-07T22:12:04.236551+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"high","headline":"Intensity Therapeutics adopts amended bylaws to strengthen shareholder proposal procedures","bullets":["Board adopted Second Amended and Restated Bylaws on Nov 21, 2023, effective immediately.","Amendments require enhanced disclosures from nominating shareholders, proposed nominees, and related persons.","New provisions address Rule 14a-19 universal proxy and Rule 14a-8 shareholder proposals.","Includes other ministerial, clarifying, and conforming changes."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-089612","json":"https://secwatch.observer/filing/0001213900-23-089612.json","markdown":"https://secwatch.observer/filing/0001213900-23-089612.md","text":"https://secwatch.observer/filing/0001213900-23-089612.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1567264/000121390023089612/0001213900-23-089612-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1567264/000121390023089612/ea188916-8k_intensity.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T22:12:04.236551+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3b7f3f8ce925d0b266fa2251b53bedfa27fd99d2","claim":"INTENSITY THERAPEUTICS, INC.: Board adopted second amended and restated bylaws effective immediately, enhancing procedural mechanics for shareholder nominations and making other updates (effective 2023-11-21).","evidence_excerpt":"On November 21, 2023, the board of directors of Intensity Therapeutics, Inc. (the “Company”) adopted the second amended and restated bylaws (the “Second Amended and Restated Bylaws”), effective immediately.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1567264/000121390023089612/0001213900-23-089612-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-11-21"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}